ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0854

The OMERACT GCA Phantom Project: Validation of 3D Printed Ultrasound Training Models for Giant Cell Arteritis

Valentin Sebastian Schäfer1, Tobias Schremmer2, Florian Recker3, Wolfgang Hartung4, Christina Duftner5, Sara Monti6, Alojzija Hocevar7, Rositsa Karalilova8, Annamaria Iagnocco9, pierluigi macchioni10, Giuseppe Antonio Germano11, ESPERANZA NAREDO12, Eugenio De Miguel13, Luca Seitz14, Thomas Daikeler15, Dennis Boumans16, Chetan Mukhtyar17, Kate Smith18, Richard Wakefield18, Andreas Diamantopoulos19, Stavros Chrysidis20, Berit Dalsgaard Nielsen21, Kresten Keller22, Uffe Moller Dohn23, Lene Terslev24, Marcin Milchert25, Wolfgang Schmidt26, George A. W. Bruyn27, Aaron Juche28 and Christian Dejaco29, 1Clinic of Internal Medicine III, Department of Rheumatology, University Hospital of Bonn, Bonn, Germany, 53127 Bonn, Nordrhein-Westfalen, Germany, 2Helios Klinikum Bonn/Rhein-Sieg, Bonn, Germany, 3Department for Gynecology and Obstetrics, University Hospital Bonn, Germany, Bonn, Germany, 4Asklepios Clinic, Tegernheim, Germany, 5Medical University Innsbruck/Tirol Kliniken GmbH, Innsbruck, Austria, 6IRCCS Istituto Auxologico Italiano, Milan, Italy, 7University Medical Center Ljubljana, LJUBLJANA, Slovenia, 8Medical University of Plovdiv, Bulgaria, Plovdiv, Bulgaria, 9University of Turin, Italy, Roma, Italy, 10SERVIZIO REUMATOLOGIA IRCCS REGGIO EMILIA, Reggio Emilia, Italy, 11Rheumatology Unit- Arcispedale Santa Maria Nuova Reggio Emilia-Italy, Reggio Emilia, Italy, 12Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, 13Hospital Universitario La Paz, Madrid, Spain, 14Inselspital, Liebefeld, Switzerland, 15university hospital, Basel, Switzerland, 16Ziekenhuisgroep Twente (Hospital Group Twente), Borne, Netherlands, 17Norfolk and Norwich University Hospital, Norwich, United Kingdom, 18NIHR Leeds Biomedical Research Centre, Leeds, UK., Leeds, United Kingdom, 19Akershus University Hospital, Lørenskog, Norway, 20Department of Rheumatology, University Hospital of Southern Denmark, Esbjerg, Denmark, 21Department of Rheumatology, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, Vejle, Denmark, 22Aarhus University Hospital, Aarhus, Denmark, 23Rigshospitalet-Glostrup, Glostrup, Denmark, 24Rigshospitalet-Glostrup & COPECARE, Glostrup, Denmark, 25Department of Rheumatology, Internal Medicine, Geriatrics and Clinical Immunology, Pomeranian Medical University, Szczecin, Poland., Szczecin, Poland, 26Immanuel Krankenhaus Berlin, Berlin, Germany, 27Reumakliniek Lelystad, Loenga, Netherlands, 28Immanuel Krankenhaus Berlin, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Berlin, Germany, 29Azienda Sanitaria Alto Adige, Brunico, Italy

Meeting: ACR Convergence 2024

Keywords: Education, giant cell arteritis, Imaging, Ultrasound, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: Imaging of Rheumatic Diseases

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Ultrasonography has been validated as a diagnostic tool for giant cell arteritis (GCA).  Due to the urgent need for glucocorticoid treatment in acute GCA and the fact that ultrasound detected inflammation normalizes rapidly upon start of treatment, it is challenging to identify patients with pathological vessels for educational purposes. The construction of realistic training model would therefore be a significant advance in GCA ultrasound training. 

We have developed a phantom of axillary (AA) and temporal arteries (TA) of GCA patients and controls using high-resolution 3D printing techniques. The aim of this study was to test the reliability of ultrasound findings using these models among experts of the large vessel vasculitis of the Outcome Measures in Rheumatology (OMERACT) ultrasound working group.

Methods: Phantoms (see Figure 1 for examples) were produced using a Formlabs SLA 3D printer and embedded in a special gelatine as a set, consisting of 3 AA or 2 TA phantoms. Participants from twelve European countries received eight sets of AA and TA phantoms. The phantoms were examined in a blinded fashion according to a predefined protocol and evaluated individually based on the OMERACT GCA definitions valid for ultrasound. In addition, the intima-media thickness (IMT) was measured. The phantoms were categorized as normal (AA&TA) / acute pathology (AA&TA) / chronic pathology (only AA) / none of the above (AA & TA). Due to wider differing results of IMT measurements and classification from the designed IMT and classification in the parietal branch of the temporal artery, TA phantoms were technically adapted and examined in a second round.

Means and standard deviations were calculated. Interrater-reliability of the classification was calculated using Fleiss-Kappa. Interrater-reliability of the IMT measurements was calculated using the one way random intra-class coefficient (ICC 1.1).

Results: Except for the parietal branch, the published cut-off values for normal and pathological IMT were met. In both rounds the phantoms were correctly classified to their designated classification in over 81% of cases yielding a Fleiss’ kappa of 0.80 (95% CI 0.78-0.81) in round 1 and 0.74 (0.72-0.75) in round 2 (see Table 1). IMT measurements revealed an intraclass correlation coefficient (ICC 1.1) of 0.98 (95% CI 0.98-0.99) in both rounds.

Conclusion: The classification of normal/abnormal phantom vessels as well as measurement of artificial IMT revealed a high reliability of GCA ultrasound among experts. It showed high agreement in correctly classifying the models and demonstrated almost perfect interrater reliability in measuring artificial IMT.

This is the first functional phantom of the temporal and axillary artery designed to train physicians in ultrasound diagnosis of GCA.

Supporting image 1

Figure 1 – Ultrasound of the phantoms
A= Normal axillary artery; B=Axillary artery with acute GCA pathology; C=Axillary artery with GCA chronic pathology; D=Normal temporal artery; E=Temporal artery with acute GCA pathology

Supporting image 2

Table 1 – Results of the IMT measurements and inter-rater reliability
Note there are no chronic phantoms of temporal arteries. (SD: standard deviation; ICC: intra-class correlation coefficient of IMT measurement; Fleiss Kappa: Fleiss Kappa for classification; CI: confidence interval)


Disclosures: V. Schäfer: None; T. Schremmer: None; F. Recker: None; W. Hartung: None; C. Duftner: None; S. Monti: AstraZeneca, 6, GlaxoSmithKlein(GSK), 6; A. Hocevar: None; R. Karalilova: None; A. Iagnocco: None; p. macchioni: None; G. Germano: None; E. NAREDO: Eli Lilly, 5, Novartis, 6; E. De Miguel: AbbVie/Abbott, 5, 6, BMS, 5, 6, Eli Lilly, 5, 6, Grunental, 5, 6, Janssen, 5, 6, Merck/MSD, 5, 6, Novartis, 5, 6, Pfizer, 5, 6, Roche, 5, 6, sanofi, 5, 6, UCB, 5, 6; L. Seitz: None; T. Daikeler: None; D. Boumans: None; C. Mukhtyar: None; K. Smith: None; R. Wakefield: None; A. Diamantopoulos: None; S. Chrysidis: None; B. Nielsen: None; K. Keller: None; U. Moller Dohn: None; L. Terslev: Eli Lilly, 6, Janssen, 1, 6, Novartis, 6, Pfizer, 6, Speakers feeJanssen, Novartis, Pfizer, UCB and GE healthcare, 6, UCB, 1; M. Milchert: None; W. Schmidt: AbbVie/Abbott, 1, 5, 6, Amgen, 1, 6, Bristol-Myers Squibb(BMS), 6, Chugai, 6, Freseanius Kabi, 1, GlaxoSmithKlein(GSK), 1, 5, 6, Johnson & Johnson, 6, medac, 6, Novartis, 1, 5, 6, Roche, 6, Sanofi, 1, 5; G. Bruyn: None; A. Juche: None; C. Dejaco: None.

To cite this abstract in AMA style:

Schäfer V, Schremmer T, Recker F, Hartung W, Duftner C, Monti S, Hocevar A, Karalilova R, Iagnocco A, macchioni p, Germano G, NAREDO E, De Miguel E, Seitz L, Daikeler T, Boumans D, Mukhtyar C, Smith K, Wakefield R, Diamantopoulos A, Chrysidis S, Nielsen B, Keller K, Moller Dohn U, Terslev L, Milchert M, Schmidt W, Bruyn G, Juche A, Dejaco C. The OMERACT GCA Phantom Project: Validation of 3D Printed Ultrasound Training Models for Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-omeract-gca-phantom-project-validation-of-3d-printed-ultrasound-training-models-for-giant-cell-arteritis-2/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-omeract-gca-phantom-project-validation-of-3d-printed-ultrasound-training-models-for-giant-cell-arteritis-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology